Research Newsroom

ABSTRACTS: 241, 566, 828, 931, 1180

Researchers from The University of Texas MD Anderson Cancer Center highlighted promising advances in cancer immunotherapy at the 2026 Society for Immunotherapy of Cancer (SITC) Annual Meeting. The presentations showcased early-phase clinical trials and preclinical studies exploring new approaches to treating advanced cancers, including solid tumors, brain cancer and melanoma. These studies offer...